<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Front Pharmacol</journal-id><journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id><journal-title-group><journal-title>Frontiers in Pharmacology</journal-title></journal-title-group><issn pub-type="epub">1663-9812</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6019502</article-id><article-id pub-id-type="doi">10.3389/fphar.2018.00652</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pharmacology</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Major Bioactive Compounds in Essential Oils Extracted From the Rhizomes of <italic>Zingiber zerumbet (L) Smith</italic>: A Mini-Review on the Anti-allergic and Immunomodulatory Properties</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tan</surname><given-names>Ji Wei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/522254/overview"/></contrib><contrib contrib-type="author"><name><surname>Israf</surname><given-names>Daud Ahmad</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/450063/overview"/></contrib><contrib contrib-type="author"><name><surname>Tham</surname><given-names>Chau Ling</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/451188/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia</institution>, <addr-line>Seri Kembangan</addr-line>, <country>Malaysia</country></aff><aff id="aff2"><sup>2</sup><institution>School of Science, Monash University Malaysia</institution>, <addr-line>Bandar Sunway</addr-line>, <country>Malaysia</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Banasri Hazra, Jadavpur University, India</p></fn><fn fn-type="edited-by"><p>Reviewed by: Yun K. Tam, Sinoveda Canada Inc., Canada; Ulrike Lindequist, University of Greifswald, Germany</p></fn><corresp id="c001">*Correspondence: Chau Ling Tham, <email>chauling@upm.edu.my</email></corresp><fn fn-type="other" id="fn002"><p>This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology</p></fn></author-notes><pub-date pub-type="epub"><day>20</day><month>6</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>652</elocation-id><history><date date-type="received"><day>30</day><month>1</month><year>2018</year></date><date date-type="accepted"><day>31</day><month>5</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Tan, Israf and Tham.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Tan, Israf and Tham</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><italic>Zingiber zerumbet (L) Smith</italic> is part of the <italic>Zingiberaceae</italic> family, one of the largest families of the plant kingdom. <italic>Z. zerumbet</italic> is a perennial, aromatic and tuberose plant that grows in humid locations where its center of distribution is located in the South-East Asia region. This plant has been traditionally used in foods and beverages and for ornamental purposes. Although many studies have reported on the biomedical applications of <italic>Z. zerumbet</italic>, the anti-allergic effects of <italic>Z. zerumbet</italic> and its major bioactive compounds have not yet been summarized in detail. Many major metabolites that have been reported to contain anti-allergic properties are terpene compounds which can be found in the essential oil extracted from the rhizomes of <italic>Z. zerumbet</italic>, such as zerumbone, limonene, and humulene. The rhizome is among the part of <italic>Z. zerumbet</italic> that has been widely used for many studies due to its exceptional biomedical applications. Most of these studies have shown that the essential oil, which can be obtained through hydro-distillation of the rhizomes from <italic>Z. zerumbet</italic>, is enriched with various active metabolites. Therefore, this mini-review provides an overview of the main aspects related to the anti-allergic and immunomodulatory properties of the major bioactive compounds found in the essential oils extracted from the rhizomes of <italic>Z. zerumbet</italic>, with the aim of demonstrating the importance of essential oil extracted from the rhizomes of <italic>Z. zerumbet</italic> and its bioactive compounds in the treatment of allergy and allergy-related diseases, in addition to other widely reported and extensively studied biomedical applications.</p></abstract><kwd-group><kwd><italic>Zingiber zerumbet</italic></kwd><kwd>rhizome</kwd><kwd>essential oil</kwd><kwd>anti-allergic</kwd><kwd>immunomodulatory</kwd><kwd>mini-review</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Malaysia Toray Science Foundation<named-content content-type="fundref-id">10.13039/501100007208</named-content></funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="53"/><page-count count="8"/><word-count count="0"/></counts></article-meta></front><body><sec><title>Introduction</title><p><italic>Zingiberaceae</italic> is the largest families of the plant kingdom. Its plants tend to be high in medicinal values and provide many useful products for food, spices, medicines, dyes, perfume and esthetics (<xref rid="B14" ref-type="bibr">Jantan et al., 2003</xref>; <xref rid="B21" ref-type="bibr">Koga et al., 2016</xref>). <italic>Zingiber</italic> is a genus of <italic>Zingiberaceae</italic> with approximately 141 species (<xref rid="B45" ref-type="bibr">Sirirugsa, 1995</xref>). <italic>Zingiber zerumbet (L) Smith</italic> is a wild ginger belonging to the <italic>Zingiber</italic> genus and is well-known among local cultures as &#x0201c;Lempoyang,&#x0201d; &#x0201c;Ghatian,&#x0201d; &#x0201c;Yaiimu,&#x0201d; &#x0201c;Jangli adha,&#x0201d; &#x0201c;Awapuhi,&#x0201d; &#x0201c;Zurunbah,&#x0201d; &#x0201c;Hong Qiu Jiang,&#x0201d; and &#x0201c;Hiao Dam.&#x0201d; This particular type of wild ginger grows naturally in damp, shaded parts of the low land and is believed to be native to India and the Malaysian Peninsula (<xref rid="B52" ref-type="bibr">Yob et al., 2011</xref>). The traditional uses of ginger are broad, including but not limited to the treatment of nausea, hangovers, migraine headache, morning and motion sickness, worm infestation in children, as well as cuts and bruised skin (<xref rid="B29" ref-type="bibr">Nik Norulaini et al., 2009</xref>; <xref rid="B7" ref-type="bibr">Butt and Sultan, 2011</xref>; <xref rid="B38" ref-type="bibr">Sahebkar, 2011</xref>). Various local groups have been using ginger to provide remedy against allergic diseases including asthma and sinusitis for centuries (<xref rid="B7" ref-type="bibr">Butt and Sultan, 2011</xref>; <xref rid="B38" ref-type="bibr">Sahebkar, 2011</xref>). As one type of wild ginger, the crude extract as well as the active compounds extracted from the rhizome and leaves of <italic>Z. zerumbet</italic> have been reported to possess various pharmacological properties including anti-inflammatory (<xref rid="B26" ref-type="bibr">Murakami et al., 2002</xref>; <xref rid="B13" ref-type="bibr">Jalil et al., 2015</xref>), antitumoral (<xref rid="B33" ref-type="bibr">Rashid and Pihie, 2005</xref>; <xref rid="B49" ref-type="bibr">Takada et al., 2005</xref>; <xref rid="B1" ref-type="bibr">Abdelwahab et al., 2010</xref>), antioxidant (<xref rid="B37" ref-type="bibr">Ruslay et al., 2007</xref>; <xref rid="B36" ref-type="bibr">Rout et al., 2011</xref>), antibacterial (<xref rid="B22" ref-type="bibr">Kumar et al., 2013</xref>), antiviral (Epstein-Barr virus) (<xref rid="B27" ref-type="bibr">Murakami et al., 1999</xref>), analgesic (<xref rid="B46" ref-type="bibr">Somchit et al., 2005</xref>), anti-allergic (<xref rid="B50" ref-type="bibr">Tewtrakul and Subhadhirasakul, 2007</xref>) characteristics and usefulness for treating stomach problems (<xref rid="B32" ref-type="bibr">Prakash et al., 2011</xref>).</p></sec><sec><title>The Anti-Allergic and Immune Modulation Activities of <italic>Z. zerumbet</italic></title><p>Although there have been quite a number of studies conducted to study the effectiveness of <italic>Z. zerumbet</italic> in a broad range of biological activities related to human health, there has been very few reported studies of <italic>Z. zerumbet</italic> as well as its bioactive compounds focusing on anti-allergy. Increasing levels of allergic diseases, such as allergic rhinitis (AR), atopic dermatitis, asthma and food allergies in many of the developed countries (<xref rid="B9" ref-type="bibr">Carlsen, 2003</xref>) are causing significant health problems, especially in children. Therefore, various research has been carried out extensively to combat these diseases (<xref rid="B31" ref-type="bibr">Pawankar et al., 2013</xref>). In one of the studies, the ethanolic and aqueous extraction of <italic>Z. zerumbet</italic> were subjected to an <italic>in vitro</italic> investigation for its anti-allergic activities (<xref rid="B50" ref-type="bibr">Tewtrakul and Subhadhirasakul, 2007</xref>). This study has shown that the ethanolic and aqueous extracts of <italic>Z. zerumbet</italic> (10&#x02013;100 &#x003bc;g/mL) inhibited the release of &#x003b2;-hexosaminidase from RBL-2H3 cells as much as 8.4&#x02013;53.7% (IC<sub>50</sub> = 91 &#x003bc;g/mL) and 10.9&#x02013;59.1% (IC<sub>50</sub> = 68.2 &#x003bc;g/mL), respectively. Several patents were filed due to the exceptional anti-allergic activities shown by <italic>Z. zerumbet</italic>. Among which, a patent by <xref rid="B10" ref-type="bibr">Chaung et al. (2009)</xref> provides a method of preparing polar solvent extraction from the root of <italic>Z. zerumbet</italic> as well as the use of this formulation to prevent or to treat an allergic disorder. Another patent by <xref rid="B24" ref-type="bibr">Lin et al. (2013)</xref> provides a method of preparing solvent extraction by using ethanol, water, or a mixture of both from the root of <italic>Z. zerumbet</italic> for treating AR or allergic eczema.</p><p>The essential oils from rhizomes of <italic>Z. zerumbet</italic> have also been shown to contain several beneficial effects such as analgesic activity (<xref rid="B47" ref-type="bibr">Sulaiman et al., 2010</xref>), anti-nociceptive activity (<xref rid="B20" ref-type="bibr">Khalid et al., 2011</xref>), and anti-microbial activity (<xref rid="B17" ref-type="bibr">Kader et al., 2010</xref>). However, anti-allergic activities involving the essential oils extracted from the rhizomes of <italic>Z. zerumbet</italic> are still yet to be well-reported. Hence, this mini-review focuses on the major bioactive compounds found in the essential oils extracted from the rhizomes of <italic>Z. zerumbet</italic> which have been reported to possess anti-allergic and immunomodulatory properties in order to improve the understanding on the use of <italic>Z. zerumbet</italic> and its bioactive compounds in the treatment of allergy and allergic-related diseases.</p></sec><sec><title>The Anti-Allergic and Immunomodulatory Activities of the Major Bioactive Compounds in the Essential Oils Extracted From the Rhizomes of <italic>Z. zerumbet</italic></title><p>Currently, there are only a few zingiber genus that have been reported to contain anti-allergic properties, including <italic>Z. officinale</italic>, <italic>Z. cassumunar</italic>, <italic>Z. zerumbet</italic>, and <italic>Z. mioga</italic> (<xref rid="B50" ref-type="bibr">Tewtrakul and Subhadhirasakul, 2007</xref>; <xref rid="B42" ref-type="bibr">Shin et al., 2015</xref>). The major bioactive compounds which can be found in the essential oil of <italic>Z. officinale</italic> are &#x003b1;-zingiberene (17.4&#x02013;32.2%), &#x003b2;-sesquiphellandrene (6.6&#x02013;27.16%), and geranial (25.9%); for <italic>Z. cassumunar</italic> is sabinene (36.71&#x02013;53.50%); for <italic>Z. zerumbet</italic> are zerumbone (35.5&#x02013;84.8%) and pinene (10.3% to 31.4%); for <italic>Z. mioga</italic> is &#x003b2;-phellandrene (26.60%) (<xref rid="B23" ref-type="bibr">Kurobayashi et al., 1991</xref>; <xref rid="B40" ref-type="bibr">Sharifi-Rad et al., 2017</xref>). Interestingly, zerumbone was found to be exclusively and abundantly present (&#x0003e;80%) in the essential oil extracted from the rhizomes of <italic>Z. zerumbet</italic>, in comparison to other major bioactive compounds extracted from <italic>Z. officinale</italic>, <italic>Z. cassumunar</italic> and <italic>Z. mioga</italic>. According to <xref rid="B41" ref-type="bibr">Shieh et al. (2015)</xref>, the anti-allergic effects of <italic>Z. zerumbet</italic> may be due to zerumbone as this compound has been shown to effectively inhibit asthma in mice. Apart from zerumbone (35.5&#x02013;84.8%), the other major compounds that can be found in the essential oils extracted from the rhizomes of <italic>Z. zerumbet</italic> are pinene (10.3&#x02013;31.4%), humulene (10.03&#x02013;17.23%), linalool (7.7&#x02013;17.1%), caryophyllene (6.9&#x02013;10.2%), borneol (4.78%), and limonene (0.8&#x02013;1.3%) (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). Among which, it is interesting to note that limonene can only be found in <italic>Z. zerumbet</italic> but not the other <italic>Zingerber</italic> genus (<xref rid="B48" ref-type="bibr">Sun, 2007</xref>; <xref rid="B3" ref-type="bibr">Bhuiyan et al., 2008</xref>).</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>The chemical structure of some of the major bioactive compounds that can be found in <italic>Zingiber zerumbet</italic>. <bold>(A)</bold> Zerumbone <bold>(B)</bold> &#x003b1;-Humulene <bold>(C)</bold> trans-Caryophyllene <bold>(D)</bold> Limonene <bold>(E)</bold> Borneol <bold>(F)</bold> &#x003b1;-Pinene <bold>(G)</bold> Linalool.</p></caption><graphic xlink:href="fphar-09-00652-g001"/></fig><p>The biomedical applications of some of these major bioactive compounds found in <italic>Z. zerumbet</italic> have been previously summarized in several review papers (<xref rid="B8" ref-type="bibr">Calder&#x000f3;n-Monta&#x000f1;o et al., 2011</xref>; <xref rid="B43" ref-type="bibr">Singh et al., 2012</xref>; <xref rid="B18" ref-type="bibr">Kalantari et al., 2017</xref>). However, the anti-allergic properties of these major bioactive compounds were not included. In this review, the major bioactive compounds found in the essential oils extracted from the rhizomes of <italic>Z. zerumbet</italic>, such as zerumbone, limonene, borneol, pinene, linalool, humulene, and caryophyllene, and their reported anti-allergic and immune modulation activities are summarized in <bold>Table <xref rid="T1" ref-type="table">1</xref></bold>.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>The major bioactive compounds found in <italic>Z. zerumbet</italic> and their reported anti-allergic and immune modulation properties.</p></caption><table frame="hsides" rules="groups" cellspacing="5" cellpadding="5"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Compound</th><th valign="top" align="left" rowspan="1" colspan="1">Experimental model</th><th valign="top" align="left" rowspan="1" colspan="1">Anti-allergic or immune modulation activities</th><th valign="top" align="left" rowspan="1" colspan="1">Concentrations/ Doses of compound used</th><th valign="top" align="left" rowspan="1" colspan="1">Mode of application</th><th valign="top" align="left" rowspan="1" colspan="1">End-point assessment</th><th valign="top" align="left" rowspan="1" colspan="1">Extraction method</th><th valign="top" align="left" rowspan="1" colspan="1">Relative quantities in the essential oil extracted from the rhizome of <italic>Z. zerumbet</italic></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Zerumbone</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>In vivo</italic>
<xref rid="B11" ref-type="bibr">Fournial et al., 2013</xref>; <xref rid="B41" ref-type="bibr">Shieh et al., 2015</xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Exhibited anti-asthmatic activities in BALB/c mice by decreasing the severity of airway hyperresponsiveness, cytokine secretions and inflammatory cells infiltration.</td><td valign="top" align="left" rowspan="1" colspan="1">0.1 &#x02013; 10 mg/kg Oral route</td><td valign="top" align="left" rowspan="1" colspan="1">Co-treatment (zerumbone administration: day 23&#x02013;39) (OVA challenge: day 28, 35&#x02013;36, 37&#x02013;39)</td><td valign="top" align="left" rowspan="1" colspan="1">Day 40</td><td valign="top" align="left" rowspan="1" colspan="1">Solvent extraction (ethanol, dichloromethane), Supercritical CO<sub>2</sub>, Hydro-distillation</td><td valign="top" align="left" rowspan="1" colspan="1">35.5&#x02013;84.8%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">New topical use for the treatment of cutaneous rednesses.</td><td valign="top" align="left" rowspan="1" colspan="1">No data</td><td valign="top" align="left" rowspan="1" colspan="1">No data</td><td valign="top" align="left" rowspan="1" colspan="1">No data</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Pinene</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>In vivo</italic>
<xref rid="B28" ref-type="bibr">Nam et al., 2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">Exhibited anti-allergic activities by reducing infiltration of inflammatory cells, IgE level and release of allergic mediators in allergic rhinitis (AR)-induced BALB/c mice.</td><td valign="top" align="left" rowspan="1" colspan="1">0.1 &#x02013; 10 mg/kg Oral route</td><td valign="top" align="left" rowspan="1" colspan="1">Pre-treatment (1 h before OVA challenge from day 15&#x02013;24) Post-treatment (1 h after OVA challenge from day 15&#x02013;24)</td><td valign="top" align="left" rowspan="1" colspan="1">Day 24</td><td valign="top" align="left" rowspan="1" colspan="1">Solvent extraction (petroleum ether, pentene and benzene), Hydro-distillation</td><td valign="top" align="left" rowspan="1" colspan="1">10.3&#x02013;31.4%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>In vitro</italic>
<xref rid="B28" ref-type="bibr">Nam et al., 2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">Inhibited activation of NF-&#x003ba;B translocation and mRNA expression of protein mediators in PMACI-induced activation of HMC-1 cells.</td><td valign="top" align="left" rowspan="1" colspan="1">0.1 &#x02013; 10 &#x003bc;g/mL</td><td valign="top" align="left" rowspan="1" colspan="1">Pre-treatment (1 h before PMACI challenge)</td><td valign="top" align="left" rowspan="1" colspan="1">8 h after challenge</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Humulene</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>In vivo</italic>
<xref rid="B35" ref-type="bibr">Rogerio et al., 2009</xref></td><td valign="top" align="left" rowspan="1" colspan="1">Exhibited anti-asthmatic activities by reducing eosinophil recruitment into the airways of BALB/c mice induced with allergic inflammation.</td><td valign="top" align="left" rowspan="1" colspan="1">50 mg/kg Oral route</td><td valign="top" align="left" rowspan="1" colspan="1">Pre-treatment (1 h before OVA challenge from day 18&#x02013;22)</td><td valign="top" align="left" rowspan="1" colspan="1">Day 22</td><td valign="top" align="left" rowspan="1" colspan="1">Solvent extraction (petroleum ether, pentene and benzene)</td><td valign="top" align="left" rowspan="1" colspan="1">10.03&#x02013;17.23%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Linalool</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>In vivo</italic>
<xref rid="B25" ref-type="bibr">Mitoshi et al., 2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">Demonstrated protective effects against DNP-human serum albumin- induced passive cutaneous anaphylaxis reaction in ICR mice.</td><td valign="top" align="left" rowspan="1" colspan="1">100 mg/kg, Oral route</td><td valign="top" align="left" rowspan="1" colspan="1">Pre-treatment (2 h before DNP-HSA challenge)</td><td valign="top" align="left" rowspan="1" colspan="1">30 min after challenge</td><td valign="top" align="left" rowspan="1" colspan="1">Solvent extraction (petroleum ether, pentene and benzene), Hydro-distillation</td><td valign="top" align="left" rowspan="1" colspan="1">7.7&#x02013;17.1%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>In vitro</italic>
<xref rid="B25" ref-type="bibr">Mitoshi et al., 2014</xref></td><td valign="top" align="left" rowspan="1" colspan="1">Exhibited anti-allergic properties in RBL-2H3 cells by reducing levels of mediators&#x02019; release.</td><td valign="top" align="left" rowspan="1" colspan="1">100 &#x003bc;g/mL</td><td valign="top" align="left" rowspan="1" colspan="1">Co-treatment (30 min with calcium ionophore challenge)</td><td valign="top" align="left" rowspan="1" colspan="1">30 min after challenge</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Caryophyllene</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>In vivo</italic>
<xref rid="B30" ref-type="bibr">Passos et al., 2007</xref>; <xref rid="B16" ref-type="bibr">Jin et al., 2011</xref></td><td valign="top" align="left" rowspan="1" colspan="1">Exhibited anti-allergic activities in OVA-evoked allergic pleurisy in Wistar rats by reducing eosinophil migration, cyclooxygenase (COX) activity and levels of mediators&#x02019; release. Exhibited anti-allergic activities in picryl chloride-induced delayed hypersensitivity in ICR mice.</td><td valign="top" align="left" rowspan="1" colspan="1">600 mg/kg, Oral route 50 - 300 mg/kg Oral route</td><td valign="top" align="left" rowspan="1" colspan="1">Pre-treatment (1 h before bee venom challenge) Post-treatment (24 h after picryl chloride or acetone challenge)</td><td valign="top" align="left" rowspan="1" colspan="1">6 h after challenge 25 h after challenge</td><td valign="top" align="left" rowspan="1" colspan="1">Solvent extraction (petroleum ether, pentene and benzene), Hydro-distillation</td><td valign="top" align="left" rowspan="1" colspan="1">6.9&#x02013;10.2%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"><italic>In vitro</italic>
<xref rid="B16" ref-type="bibr">Jin et al., 2011</xref></td><td valign="top" align="left" rowspan="1" colspan="1">Exhibited anti-allergic properties in rat basophilic leukemia (RBL)-1 cells by reducing 5-lipoxygenase (LOX) inhibitory activity as well as levels of mediators&#x02019; release.</td><td valign="top" align="left" rowspan="1" colspan="1">30 &#x02013; 300 &#x003bc;g/mL</td><td valign="top" align="left" rowspan="1" colspan="1">Pre-treatment (10 min before calcium ionophore challenge)</td><td valign="top" align="left" rowspan="1" colspan="1">10 min after challenge</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Borneol</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>In vivo</italic>
<xref rid="B51" ref-type="bibr">Watanabe et al., 1994</xref></td><td valign="top" align="left" rowspan="1" colspan="1">Exerted inhibitory effects on histamine release from abdominal mast cells induced by ovalbumin (OVA).</td><td valign="top" align="left" rowspan="1" colspan="1">No data</td><td valign="top" align="left" rowspan="1" colspan="1">No data</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">Solvent extraction (petroleum ether, pentene and benzene)</td><td valign="top" align="left" rowspan="1" colspan="1">4.78%</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Limonene</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>In vivo</italic>
<xref rid="B12" ref-type="bibr">Hirota et al., 2012</xref></td><td valign="top" align="left" rowspan="1" colspan="1">Reduced <italic>Dermatophagoides farinae</italic>-induced airway remodeling and airway hyperresponsiveness (AHR) in BALB/c mice.</td><td valign="top" align="left" rowspan="1" colspan="1">1 mg/kg Intranasal</td><td valign="top" align="left" rowspan="1" colspan="1">Pre-treatment (1 h before OVA challenge from day 27&#x02013;29)</td><td valign="top" align="left" rowspan="1" colspan="1">Day 30</td><td valign="top" align="left" rowspan="1" colspan="1">Hydro-distillation</td><td valign="top" align="left" rowspan="1" colspan="1">0.8&#x02013;1.3%</td></tr></tbody></table></table-wrap><sec><title>Zerumbone</title><p>Zerumbone is a sesquiterpene compound abundantly present (35.5&#x02013;84.8%) in essential oils extracted from the rhizomes of <italic>Z. zerumbet</italic> (<xref rid="B50" ref-type="bibr">Tewtrakul and Subhadhirasakul, 2007</xref>; <xref rid="B40" ref-type="bibr">Sharifi-Rad et al., 2017</xref>). A study done by <xref rid="B41" ref-type="bibr">Shieh et al. (2015)</xref> showed that zerumbone isolated from <italic>Z. zerumbet</italic> decreased the severity of airway hyperresponsiveness and the accumulation of eosinophils in bronchoalveolar lavage fluid (BALF) collected from OVA-challenge female BALB/c mice. The oral administration of zerumbone (0.1, 1, and 10 mg/kg) also significantly reduced serum anti-OVA IgE levels in mice (<xref rid="B41" ref-type="bibr">Shieh et al., 2015</xref>), which further resulted in the reduction of OVA-induced cytokine secretions (IL-4, IL-5, IL-10, and IL-13) in the BALF collected (<xref rid="B41" ref-type="bibr">Shieh et al., 2015</xref>). Thus, the authors speculated that zerumbone may have an anti-allergic effect on allergic asthma by suppressing Th2-related cytokines (IL-4, IL-5, IL-10, and IL-13) secretion and consequently reducing IgE production by B cells (<xref rid="B41" ref-type="bibr">Shieh et al., 2015</xref>). The data reported in this study was the first known report to provide a rationale for extensive preclinical studies on zerumbone in IgE-mediated allergic asthma.</p></sec><sec><title>Pinene</title><p>Pinene is a monoterpene compound that can be isolated from <italic>Z. zerumbet</italic> (<xref rid="B21" ref-type="bibr">Koga et al., 2016</xref>) in relatively higher quantities (10.3&#x02013;31.4%) than other plants from the same genus. The percentages of pinene found in <italic>Z. corallinum</italic> and <italic>Z. cassumunar</italic> were only 2.16&#x02013;3.23% and 5.2&#x02013;7.25%, respectively (<xref rid="B21" ref-type="bibr">Koga et al., 2016</xref>). In addition, pinene has been reported to attenuate OVA-induced AR in female BALB/c mice by decreasing the infiltration of eosinophils and mast cells in AR nasal mucosa tissue, as well as reducing the level of TNF-&#x003b1; and number of nose rubs in mice orally pre-treated with &#x003b1;-pinene (0.1, 1, or 10 mg/kg) (<xref rid="B28" ref-type="bibr">Nam et al., 2014</xref>). The authors even demonstrated that post-treatment of &#x003b1;-pinene in the OVA-induced mice significantly decreased nasal mucosa IgE level and the number of nose rubs (<xref rid="B28" ref-type="bibr">Nam et al., 2014</xref>). The <italic>in vitro</italic> study also reported that &#x003b1;-pinene (0.1, 1, or 10 &#x003bc;g/mL) inhibits the production and mRNA expression of TNF-&#x003b1; in PMACI-induced activation of HMC-1 cells (<xref rid="B28" ref-type="bibr">Nam et al., 2014</xref>). In term of regulatory mechanism of &#x003b1;-pinene on allergic inflammation, this compound inhibits PMACI-induced activation of NF-&#x003ba;B and IKK-&#x003b2; in HMC-1 cells (<xref rid="B28" ref-type="bibr">Nam et al., 2014</xref>). In conclusion, that study suggested that &#x003b1;-pinene was able to exert its anti-allergic effects by interfering the NF-&#x003ba;B/I&#x003ba;B signaling pathway as this pathway is closely related with the inhibition of allergic inflammation in human mast cells (<xref rid="B44" ref-type="bibr">Singh et al., 2011</xref>).</p></sec><sec><title>Humulene</title><p>Similar to zerumbone, humulene is a sesquiterpene compound that can be found abundantly (10.03&#x02013;17.23%) in <italic>Z. zerumbet</italic> (<xref rid="B2" ref-type="bibr">Baby et al., 2009</xref>). Its key enzyme, &#x003b1;-humulene synthase, has been shown to play a part in the synthesis of zerumbone (<xref rid="B2" ref-type="bibr">Baby et al., 2009</xref>). However, other <italic>Zingiber</italic> species such as <italic>Z. nimmonii</italic> and <italic>Z. cassumunar</italic> have been shown to contain higher levels of humulene (19.6&#x02013;27.7% and 23.92%, respectively), in comparison to <italic>Z. zerumbet</italic>. <xref rid="B35" ref-type="bibr">Rogerio et al. (2009)</xref> reported on the inhibitory effect of &#x003b1;-humulene on OVA-induced airway allergic inflammation in female BALB/c mice. They showed that therapeutic treatment with &#x003b1;-humulene (50 mg/kg) may be able to decrease leukocyte recruitment (neutrophils, eosinophils and mononuclear) as well as allergic associated mediators including leukotriene (LT)B<sub>4</sub> and IL-5 levels in the BALF (<xref rid="B35" ref-type="bibr">Rogerio et al., 2009</xref>). The immunohistochemistry staining in this study also revealed the inhibitory effects of &#x003b1;-humulene on the phosphorylation of p65 NF-kB and c-Jun AP-1 subunits, which are the two important modulators for the control production of the Th2 cytokine, IL-5 and the recruitment of leukocytes (<xref rid="B35" ref-type="bibr">Rogerio et al., 2009</xref>). These results suggest the potential of &#x003b1;-humulene as a candidate for the treatment of asthma and other allergic diseases.</p></sec><sec><title>Linalool</title><p>Linalool is a monoterpene in <italic>Z. zerumbet</italic> that contributes to the aromatic scent of this plant (7.7&#x02013;17.1%) (<xref rid="B2" ref-type="bibr">Baby et al., 2009</xref>). In one study, linalool and other 20 types of natural compounds were shown to inhibit &#x003b2;-hexosaminidase release at the concentration of 100 &#x003bc;g/mL in RBL-2H3 cells induced with calcium ionophore, A23187 (<xref rid="B25" ref-type="bibr">Mitoshi et al., 2014</xref>). The study also demonstrated the protective effects of orally administered linalool (100 mg/kg) against DNP-HSA induced passive cutaneous anaphylaxis (PCA) reaction in mice whereby linalool significantly reduced the amount of Evans blue dye present in the exudates collected from ear samples (<xref rid="B25" ref-type="bibr">Mitoshi et al., 2014</xref>). In the discussion it was hypothesized that the anti-allergic effects of linalool may be at least in part dependent on the inhibition of NF-&#x003ba;B activation (<xref rid="B25" ref-type="bibr">Mitoshi et al., 2014</xref>). However, further investigation should be carried out, as its underlying molecular mechanism remains unelucidated.</p></sec><sec><title>Caryophyllene</title><p>Caryophyllene, one of the natural bicyclic sesquiterpenes in <italic>Z. zerumbet</italic>, contributes to the spiciness taste of this plant (<xref rid="B2" ref-type="bibr">Baby et al., 2009</xref>). In comparison to <italic>Z. nimmonii</italic> and <italic>Z. officinale</italic> which have been reported to possess 26.9&#x02013;42.2% and 15.29% of caryophyllene, respectively, <italic>Z. zerumbet</italic> has a relative lower quantity of caryophyllene (6.9&#x02013;10.2%). Studies have shown that the oral administration of caryophyllene significantly inhibited the oedematogenic response caused by <italic>Apis mellifera</italic> venom in the OVA-sensitized male Wistar rat paws (<xref rid="B30" ref-type="bibr">Passos et al., 2007</xref>). Furthermore, the administration of caryophyllene significantly reduced the eosinophil migration at the site of venom induction, leading to reduced levels of tumor necrosis factor alpha (TNF-&#x003b1;), prostaglandin E2 (PGE<sub>2</sub>) and COX activity (<xref rid="B30" ref-type="bibr">Passos et al., 2007</xref>). These results strongly suggest the potential of caryophyllene in the treatment of allergic conditions.</p><p>Another study conducted by <xref rid="B16" ref-type="bibr">Jin et al. (2011)</xref> demonstrated that preincubation of caryophyllene (100 &#x003bc;M) with rat basophilic leukemia-1 (RBL-1) was able to significantly reduce 5-LOX inhibitory activity as well as the release of cysteinyl LTs (LTC<sub>4</sub>/D<sub>4</sub>/E<sub>4</sub>), and the effect was more prominent in comparison to the other two bioactive compounds of <italic>Z. zerumbet</italic> - limonene and pinene (<xref rid="B16" ref-type="bibr">Jin et al., 2011</xref>). Caryophyllene also significantly attenuated the antigen-induced degranulation of &#x003b2;-hexosaminidase and phosphorylation of Lyn molecules in RBL-2H3 cell culture (<xref rid="B16" ref-type="bibr">Jin et al., 2011</xref>). Furthermore, the <italic>in vivo</italic> immune modulatory effects of caryophyllene were also demonstrated. Caryophyllene was able to significantly inhibit the picryl chloride-induced delayed type hypersensitivity (DTH) response in mice, when given orally (100&#x02013;300 mg/kg), as evidenced by decreased measurements in the ear thickness of mice (<xref rid="B16" ref-type="bibr">Jin et al., 2011</xref>). These findings concluded that caryophyllene exerts anti-allergic activity against mast cell degranulation and offers immune modulatory effects against DTH.</p></sec><sec><title>Limonene</title><p>Limonene is the only major bioactive compound found exclusively in <italic>Z. zerumbet</italic> in the Zingiberaceae family (<xref rid="B21" ref-type="bibr">Koga et al., 2016</xref>). Limonene has shown a potent reduction in the airway inflammatory reactions with improving asthma symptoms in <italic>Dermatophagoides farinae</italic>-induced allergic airway inflammation of male BALB/c mice (<xref rid="B12" ref-type="bibr">Hirota et al., 2012</xref>). One study demonstrated a lowered level of serum total IgE, allergen specific IgG<sub>1</sub> and allergic associated mediators (IL-5 and IL-13) in mice after inhalation of limonene (1 mg/kg) (<xref rid="B12" ref-type="bibr">Hirota et al., 2012</xref>). Additionally, limonene was able to decrease AHR in mice by suppressing the number of eosinophils found in the collected BALF (<xref rid="B12" ref-type="bibr">Hirota et al., 2012</xref>). It also significantly reversed allergen-induced lung histopathological changes in mice by lowering perivascular and peribronchial infiltration of eosinophils, goblet cells hyperplasia, airway fibrosis and smooth muscle thickness (<xref rid="B12" ref-type="bibr">Hirota et al., 2012</xref>). These findings have shown that limonene may be beneficial as a prophylactic and therapeutic agent for asthma in the future.</p></sec></sec><sec><title>Discussion</title><p>Most major bioactive compounds found in the essential oils extracted from the rhizome of <italic>Z. zerumbet</italic> are terpene compounds with long hydrocarbon tails, generally resulting in low polarity (<xref rid="B15" ref-type="bibr">Jiang et al., 2016</xref>). As such, a few preferred ways of extracting terpene compounds from <italic>Z. zerumbet</italic> are hydro-distillation and solvent extraction using organic solvents such as ethanol and methanol; or non-polar solvents such as petroleum ether, pentene, hexane, and benzene (<xref rid="B18" ref-type="bibr">Kalantari et al., 2017</xref>). A previous study by <xref rid="B50" ref-type="bibr">Tewtrakul and Subhadhirasakul (2007)</xref> showed that an ethanolic extract of <italic>Z. zerumbet</italic> containing both polar and non-polar compounds exhibited exceptional anti-allergic effects by inhibiting the release of &#x003b2;-hexosaminidase from RBL-2H3 cells. However, not much attention has been given to the anti-allergic effects of other extracts from <italic>Z. zerumbet</italic> and particularly essential oil, in which the main constituent is zerumbone. Although it has once been reported that the essential oil of <italic>Z. zerumbet</italic> failed to inhibit &#x003b2;-hexosaminidase, the reported yield of essential oil from the whole plant of <italic>Z. zerumbet</italic> in that study was only 3.0%, in comparison to other studies reporting yields ranging from 5 to 13% (<xref rid="B33" ref-type="bibr">Rashid and Pihie, 2005</xref>; <xref rid="B53" ref-type="bibr">da Silva et al., 2017</xref>). It is also important to note that the essential oils used in that particular study were extracted from the whole plant but not the rhizomes of <italic>Z. zerumbet</italic> alone (<xref rid="B50" ref-type="bibr">Tewtrakul and Subhadhirasakul, 2007</xref>). Low levels of bioactive compounds present in the yield in particular terpene compounds may be too low to significantly exhibit an anti-allergic response. Further studies should be carried out with higher yield of extracted essential oil from the rhizomes of <italic>Z. zerumbet</italic>. Distilled hexane can be added during the hydro-distillation process to increase the yield of oil extracted from <italic>Z. zerumbet</italic> (<xref rid="B29" ref-type="bibr">Nik Norulaini et al., 2009</xref>). It would be interesting to study whether the essential oils extracted from the rhizomes of <italic>Z. zerumbet</italic> exhibit anti-allergic response as the extracted oil particularly from the rhizomes of <italic>Z. zerumbet</italic> has been proven to have many beneficial properties such as analgesic activity (<xref rid="B47" ref-type="bibr">Sulaiman et al., 2010</xref>), anti-nociceptive activity (<xref rid="B20" ref-type="bibr">Khalid et al., 2011</xref>) and anti-microbial activity (<xref rid="B17" ref-type="bibr">Kader et al., 2010</xref>).</p><p>Due to the presence of various bioactive compounds in a plant extract, it is difficult to confirm which bioactive compound contributes to the intended beneficial effects in a disease model (<xref rid="B39" ref-type="bibr">Sasidharan et al., 2011</xref>; <xref rid="B19" ref-type="bibr">Katiyar et al., 2012</xref>). Therefore, it would be much preferable to identify and isolate the major bioactive compounds present in a plant extract and study them individually. Since many major bioactive compounds found in the essential oil extracted from the rhizomes of <italic>Z. zerumbet</italic> have been shown to be effective in treating allergic responses, it would be important to know whether the doses used in these studies are practical to be translated into clinical studies. The highest oral doses of <italic>Z. zerumbet</italic> extract used in rats and mice were 600 and 300 mg/kg, respectively, equivalent to 97 and 24 mg/kg in humans, according to the human equivalent dose equation (<xref rid="B34" ref-type="bibr">Reagan-Shaw et al., 2016</xref>). In terms of bioactive compounds, the highest oral dose of purified zerumbone compound isolated from <italic>Z. zerumbet</italic> used in mice was 10 mg/kg, which is equivalent to 0.81 mg/kg when translated for human consumption. When the translated doses of these bioactive compounds are compared with cromolyn sodium, which is a well-known standard mast cell stabilizer used in many clinical studies to treat various allergic diseases (<xref rid="B4" ref-type="bibr">Burgher et al., 1971</xref>; <xref rid="B6" ref-type="bibr">Businco et al., 1983</xref>; <xref rid="B5" ref-type="bibr">Burks and Sampson, 1988</xref>), the doses used ranging from 8 to 40 mg/kg. Although all of the bioactive compounds found in the essential oil extracted from the rhizomes of <italic>Z. zerumbet</italic> reported in this mini-review are yet to enter clinical trials, this mini-review provides an insight of the recommended doses to be used in any future studies involving these bioactive compounds. Comparisons of the doses used in animal and human studies also indicate the potential of these bioactive compounds to be developed as therapies for the treatment of allergy and allergic-related diseases in future.</p></sec><sec><title>Conclusion</title><p>This mini-review summarizes the anti-allergic and immunomodulatory properties of the major bioactive compounds found in the essential oil extracted from the rhizomes of <italic>Z. zerumbet</italic> in order to demonstrate the importance of <italic>Z. zerumbet</italic> in the treatment of allergy and allergic-related diseases, in addition to the other biomedical applications which have been widely reported and extensively studied. Future studies should focus in-depth on exploring the potential therapeutic applications of the major bioactive compounds found in the essential oil extracted from the rhizomes of <italic>Z. zerumbet</italic> toward various allergy-related diseases. It is also important to dissect the mechanism of action of these major bioactive compounds in order to determine how they exert their anti-allergic properties.</p></sec><sec><title>Author Contributions</title><p>JT and CT prepared the manuscript. DI reviewed the drafts and provided important information for the completion of this manuscript. CT conceived the idea, reviewed the drafts, and provided important information for the completion of this manuscript.</p></sec><sec><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This material is based on work supported by the Malaysia Toray Science Foundation and Putra Grant - Putra Young Initiative (IPM) (GP-IPM/2015/9455600). JT is a recipient of MyPhD scholarship under MyBrain15 program.</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelwahab</surname><given-names>S. I.</given-names></name><name><surname>Abdul</surname><given-names>A. B.</given-names></name><name><surname>Devi</surname><given-names>N.</given-names></name><name><surname>Taha</surname><given-names>M. M. E.</given-names></name><name><surname>Al-Zubairi</surname><given-names>A. S.</given-names></name><name><surname>Mohan</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Regression of cervical intraepithelial neoplasia by zerumbone in female Balb/c mice prenatally exposed to diethylstilboestrol: involvement of mitochondria-regulated apoptosis.</article-title>
<source><italic>Exp. Toxicol. Pathol.</italic></source>
<volume>62</volume>
<fpage>461</fpage>&#x02013;<lpage>469</lpage>. <pub-id pub-id-type="doi">10.1016/j.etp.2009.06.005</pub-id>
<?supplied-pmid 19581075?><pub-id pub-id-type="pmid">19581075</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baby</surname><given-names>S.</given-names></name><name><surname>Dan</surname><given-names>M.</given-names></name><name><surname>Thaha</surname><given-names>A. R. M.</given-names></name><name><surname>Johnson</surname><given-names>A. J.</given-names></name><name><surname>Kurup</surname><given-names>R.</given-names></name><name><surname>Balakrishnapillai</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>High content of zerumbone in volatile oils of <italic>Zingiber zerumbet</italic> from southern India and Malaysia.</article-title>
<source><italic>Flavour Frag. J.</italic></source>
<volume>24</volume>
<fpage>301</fpage>&#x02013;<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1002/ffj.1940</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhuiyan</surname><given-names>M. N. I.</given-names></name><name><surname>Chowdhury</surname><given-names>J. U.</given-names></name><name><surname>Begum</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Chemical investigation of the leaf and rhizome essential oils of <italic>Zingiber zerumbet</italic> (L.) Smith from bangladesh.</article-title>
<source><italic>Bangladesh J. Pharmacol.</italic></source>
<volume>4</volume>
<fpage>9</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.3329/bjp.v4i1.845</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burgher</surname><given-names>L. W.</given-names></name><name><surname>Elliott</surname><given-names>R. M.</given-names></name><name><surname>Kass</surname><given-names>I.</given-names></name></person-group> (<year>1971</year>). <article-title>A perspective on the role of cromolyn sodium as an antiasthmatic agent.</article-title>
<source><italic>Chest</italic></source>
<volume>60</volume>
<fpage>210</fpage>&#x02013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1378/chest.60.3.210</pub-id><pub-id pub-id-type="pmid">4106050</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burks</surname><given-names>A. W.</given-names></name><name><surname>Sampson</surname><given-names>H. A.</given-names></name></person-group> (<year>1988</year>). <article-title>Double-blind placebo-controlled trial of oral cromolyn in children with atopic dermatitis and documented food hypersensitivity.</article-title>
<source><italic>J. Allergy Clin. Immunol.</italic></source>
<volume>81</volume>
<fpage>417</fpage>&#x02013;<lpage>423</lpage>. <pub-id pub-id-type="doi">10.1016/0091-6749(88)90910-4</pub-id>
<?supplied-pmid 3123539?><pub-id pub-id-type="pmid">3123539</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Businco</surname><given-names>L.</given-names></name><name><surname>Cantani</surname><given-names>A.</given-names></name><name><surname>Benincori</surname><given-names>N.</given-names></name><name><surname>Perlini</surname><given-names>R.</given-names></name><name><surname>Infussi</surname><given-names>R.</given-names></name><name><surname>De Angelis</surname><given-names>M.</given-names></name><etal/></person-group> (<year>1983</year>). <article-title>Effectiveness of oral sodium cromoglycate (SCG) in preventing food allergy in children.</article-title>
<source><italic>Ann. Allergy</italic></source>
<volume>51</volume>
<fpage>47</fpage>&#x02013;<lpage>50</lpage>. <?supplied-pmid 6408951?><pub-id pub-id-type="pmid">6408951</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butt</surname><given-names>M. S.</given-names></name><name><surname>Sultan</surname><given-names>M. T.</given-names></name></person-group> (<year>2011</year>). <article-title>Ginger and its health claims: molecular aspects.</article-title>
<source><italic>Crit. Rev. Food Sci. Nutr.</italic></source>
<volume>51</volume>
<fpage>383</fpage>&#x02013;<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1080/10408391003624848</pub-id>
<?supplied-pmid 21491265?><pub-id pub-id-type="pmid">21491265</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder&#x000f3;n-Monta&#x000f1;o</surname><given-names>J. M.</given-names></name><name><surname>Burgos-Mor&#x000f3;n</surname><given-names>E.</given-names></name><name><surname>P&#x000e9;rez-Guerrero</surname><given-names>C.</given-names></name><name><surname>L&#x000f3;pez-L&#x000e1;zaro</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>A review on the dietary flavonoid kaempferol.</article-title>
<source><italic>Mini Rev. Med. Chem.</italic></source>
<volume>11</volume>
<fpage>298</fpage>&#x02013;<lpage>344</lpage>. <pub-id pub-id-type="doi">10.2174/138955711795305335</pub-id><pub-id pub-id-type="pmid">21428901</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlsen</surname><given-names>K. H.</given-names></name></person-group> (<year>2003</year>). <article-title>Can asthma and allergy be prevented in real life?</article-title>
<source><italic>Allergy</italic></source>
<volume>58</volume>
<fpage>730</fpage>&#x02013;<lpage>732</lpage>. <pub-id pub-id-type="doi">10.1034/j.1398-9995.2003.00257.x</pub-id><pub-id pub-id-type="pmid">12859550</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chaung</surname><given-names>H. C.</given-names></name><name><surname>Huang</surname><given-names>C. S.</given-names></name><name><surname>Lee</surname><given-names>F. Y.</given-names></name><name><surname>Lin</surname><given-names>T. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Immune modulation and anti-allergy activities of</article-title>
<source><italic>Zingiber zerumbet.</italic></source>
<comment>U.S. Patent No. US7588788 B2</comment>
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>U.S. Patent and Trademark Office</publisher-name>.</mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>T. M.</given-names></name><name><surname>Pinheiro</surname><given-names>C. D.</given-names></name><name><surname>Orlandi</surname><given-names>P. P.</given-names></name><name><surname>Pinheiro</surname><given-names>C. C.</given-names></name><name><surname>Pontes</surname><given-names>G. S.</given-names></name></person-group> (<year>2017</year>). <article-title>Zerumbone from <italic>Zingiber zerumbet</italic> (L.) smith: a potential prophylactic and therapeutic agent against the cariogenic bacterium <italic>Streptococcus mutans</italic>.</article-title>
<source><italic>bioRxiv</italic></source>
<comment>[Preprint]</comment>
<pub-id pub-id-type="doi">10.1101/187906</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fournial</surname><given-names>A.</given-names></name><name><surname>Grizaud</surname><given-names>C. M.</given-names></name><name><surname>Mondon</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <comment>New topical use of zerumbone. U.S. Patent No. WO2013105047 A2</comment>
<publisher-loc>Washington, DC</publisher-loc>: <publisher-name>U.S. Patent and Trademark Office</publisher-name>.</mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirota</surname><given-names>R.</given-names></name><name><surname>Nakamura</surname><given-names>H.</given-names></name><name><surname>Bhatti</surname><given-names>S. A.</given-names></name><name><surname>Ngatu</surname><given-names>N. R.</given-names></name><name><surname>Muzembo</surname><given-names>B. A.</given-names></name><name><surname>Dumavibhat</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Limonene inhalation reduces allergic airway inflammation in <italic>Dermatophagoides farinae</italic>-treated mice.</article-title>
<source><italic>Inhal. Toxicol.</italic></source>
<volume>24</volume>
<fpage>373</fpage>&#x02013;<lpage>381</lpage>. <pub-id pub-id-type="doi">10.3109/08958378.2012.675528</pub-id>
<?supplied-pmid 22564095?><pub-id pub-id-type="pmid">22564095</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jalil</surname><given-names>M.</given-names></name><name><surname>Annuar</surname><given-names>M. S. M.</given-names></name><name><surname>Tan</surname><given-names>B. C.</given-names></name><name><surname>Khalid</surname><given-names>N.</given-names></name></person-group> (<year>2015</year>). <article-title>Effects of selected physicochemical parameters on zerumbone production of <italic>Zingiber zerumbet</italic> Smith cell suspension culture.</article-title>
<source><italic>Evid. Based Complement. Alternat.</italic></source>
<volume>2015</volume>:<issue>757514</issue>. <pub-id pub-id-type="doi">10.1155/2015/757514</pub-id>
<?supplied-pmid 25767555?><pub-id pub-id-type="pmid">25767555</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jantan</surname><given-names>I.</given-names></name><name><surname>Yassin</surname><given-names>M.</given-names></name><name><surname>Chin</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Sim</surname><given-names>N.</given-names></name></person-group> (<year>2003</year>). <article-title>Antifungal activity of the essential oils of nine Zingiberaceae species.</article-title>
<source><italic>Pharm. Biol.</italic></source>
<volume>41</volume>
<fpage>392</fpage>&#x02013;<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1076/phbi.41.5.392.15941</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Kempinski</surname><given-names>C.</given-names></name><name><surname>Chappell</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Extraction and Analysis of Terpenes/Terpenoids.</article-title>
<source><italic>Curr. Protoc. Plant Biol.</italic></source>
<volume>1</volume>
<fpage>345</fpage>&#x02013;<lpage>358</lpage>. <pub-id pub-id-type="doi">10.1002/cppb.20024</pub-id>
<?supplied-pmid 27868090?><pub-id pub-id-type="pmid">27868090</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>J. H.</given-names></name><name><surname>Lee</surname><given-names>D. U.</given-names></name><name><surname>Kim</surname><given-names>Y. S.</given-names></name><name><surname>Kim</surname><given-names>H. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Anti-allergic activity of sesquiterpenes from the rhizomes of <italic>Cyperus rotundus</italic>.</article-title>
<source><italic>Arch. Pharm. Res.</italic></source>
<volume>34</volume>
<fpage>223</fpage>&#x02013;<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1007/s12272-011-0207-z</pub-id>
<?supplied-pmid 21380805?><pub-id pub-id-type="pmid">21380805</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kader</surname><given-names>M. G.</given-names></name><name><surname>Habib</surname><given-names>M. R.</given-names></name><name><surname>Nikkon</surname><given-names>F.</given-names></name><name><surname>Yeasmin</surname><given-names>T.</given-names></name><name><surname>Rahid</surname><given-names>M. A.</given-names></name><name><surname>Rahman</surname><given-names>M. M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Zederone from the rhizomes of <italic>Zingier zerumbet</italic> and its anti-staphylococcal activity.</article-title>
<source><italic>Bol. Latinoam. Caribe Plant. Med. Arom.</italic></source>
<volume>9</volume>
<fpage>63</fpage>&#x02013;<lpage>68</lpage>.</mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalantari</surname><given-names>K.</given-names></name><name><surname>Moniri</surname><given-names>M.</given-names></name><name><surname>Boroumand Moghaddam</surname><given-names>A.</given-names></name><name><surname>Abdul Rahim</surname><given-names>R.</given-names></name><name><surname>Bin Ariff</surname><given-names>A.</given-names></name><name><surname>Izadiyan</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>A review of the biomedical applications of Zerumbone and the techniques for its extraction from ginger rhizomes.</article-title>
<source><italic>Molecules</italic></source>
<volume>22</volume>:<issue>E1645</issue>. <pub-id pub-id-type="doi">10.3390/molecules22101645</pub-id>
<?supplied-pmid 28974019?><pub-id pub-id-type="pmid">28974019</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katiyar</surname><given-names>C.</given-names></name><name><surname>Gupta</surname><given-names>A.</given-names></name><name><surname>Kanjilal</surname><given-names>S.</given-names></name><name><surname>Katiyar</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Drug discovery from plant sources: an integrated approach.</article-title>
<source><italic>Ayu</italic></source>
<volume>33</volume>
<fpage>10</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.4103/0974-8520.100295</pub-id>
<?supplied-pmid 23049178?><pub-id pub-id-type="pmid">23049178</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khalid</surname><given-names>M. H.</given-names></name><name><surname>Akhtar</surname><given-names>M. N.</given-names></name><name><surname>Mohamad</surname><given-names>A. S.</given-names></name><name><surname>Perimal</surname><given-names>E. K.</given-names></name><name><surname>Akira</surname><given-names>A.</given-names></name><name><surname>Israf</surname><given-names>D. A.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Antinociceptive effect of the essential oil of <italic>Zingiber zerumbet</italic> in mice: possible mechanisms.</article-title>
<source><italic>J. Ethnopharmacol.</italic></source>
<volume>137</volume>
<fpage>345</fpage>&#x02013;<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2011.05.043</pub-id>
<?supplied-pmid 21664960?><pub-id pub-id-type="pmid">21664960</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koga</surname><given-names>A. Y.</given-names></name><name><surname>Beltrame</surname><given-names>F. L.</given-names></name><name><surname>Pereira</surname><given-names>A. V.</given-names></name></person-group> (<year>2016</year>). <article-title>Several aspects of <italic>Zingiber zerumbet</italic>: a review.</article-title>
<source><italic>Rev. Bras. Farmacogn.</italic></source>
<volume>26</volume>
<fpage>385</fpage>&#x02013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1016/j.bjp.2016.01.006</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S. C. S.</given-names></name><name><surname>Srinivas</surname><given-names>P.</given-names></name><name><surname>Bettadaiah</surname><given-names>B. K.</given-names></name></person-group> (<year>2013</year>). <article-title>Antibacterial and antimutagenic activities of novel zerumbone analogues.</article-title>
<source><italic>Food Chem.</italic></source>
<volume>141</volume>
<fpage>1097</fpage>&#x02013;<lpage>1103</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2013.04.021</pub-id>
<?supplied-pmid 23790891?><pub-id pub-id-type="pmid">23790891</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurobayashi</surname><given-names>Y.</given-names></name><name><surname>Sakakibara</surname><given-names>H.</given-names></name><name><surname>Yanai</surname><given-names>T.</given-names></name><name><surname>Yajima</surname><given-names>I.</given-names></name><name><surname>Hayashi</surname><given-names>K.</given-names></name></person-group> (<year>1991</year>). <article-title>Volatile flavor compounds of Myoga (<italic>Zingiber Mioga</italic>).</article-title>
<source><italic>Agric. Biol. Chem.</italic></source>
<volume>55</volume>
<fpage>1655</fpage>&#x02013;<lpage>1657</lpage>.</mixed-citation></ref><ref id="B24"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>T. C.</given-names></name><name><surname>Chaung</surname><given-names>H. C.</given-names></name><name><surname>Huang</surname><given-names>C. S.</given-names></name><name><surname>Lee</surname><given-names>F. Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Anti-allergy activities of</article-title>
<source><italic>Zingiber zerumbet</italic></source>
<comment>(L.) smith. European Patent No. EP1781235 B1</comment>
<publisher-loc>Munich</publisher-loc>: <publisher-name>European Patent Office</publisher-name>.</mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitoshi</surname><given-names>M.</given-names></name><name><surname>Kuriyama</surname><given-names>I.</given-names></name><name><surname>Nakayama</surname><given-names>H.</given-names></name><name><surname>Miyazato</surname><given-names>H.</given-names></name><name><surname>Sugimoto</surname><given-names>K.</given-names></name><name><surname>Kobayashi</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Suppression of allergic and inflammatory responses by essential oils derived from herbal plants and citrus fruits.</article-title>
<source><italic>Int. J. Mol. Med.</italic></source>
<volume>33</volume>
<fpage>1643</fpage>&#x02013;<lpage>1651</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2014.1720</pub-id>
<?supplied-pmid 24682420?><pub-id pub-id-type="pmid">24682420</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>A.</given-names></name><name><surname>Takahashi</surname><given-names>D.</given-names></name><name><surname>Kinoshita</surname><given-names>T.</given-names></name><name><surname>Koshimizu</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>H. W.</given-names></name><name><surname>Yoshihiro Nakamura</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Zerumbone, a South east Asian ginger sesquiterpene, markedly suppresses free radical generation, pro-inflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the unsaturated carbonyl group is a prerequisite.</article-title>
<source><italic>Carcinogenesis</italic></source>
<volume>23</volume>
<fpage>795</fpage>&#x02013;<lpage>802</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/23.5.795</pub-id><pub-id pub-id-type="pmid">12016152</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>A.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Jiwajinda</surname><given-names>S.</given-names></name><name><surname>Koshimizu</surname><given-names>K.</given-names></name><name><surname>Ohigashi</surname><given-names>H.</given-names></name></person-group> (<year>1999</year>). <article-title>Identification of zerumbone in <italic>Zingiber zerumbet</italic> Smith as a potent inhibitor of 12-o-tetradecanoylphorbol-13-acetate-induced Epstein-barr virus activation.</article-title>
<source><italic>Biosci. Biotechnol. Biochem.</italic></source>
<volume>63</volume>
<fpage>1811</fpage>&#x02013;<lpage>1812</lpage>. <pub-id pub-id-type="doi">10.1271/bbb.63.1811</pub-id>
<?supplied-pmid 10586508?><pub-id pub-id-type="pmid">10586508</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>S. Y.</given-names></name><name><surname>Chung</surname><given-names>C. K.</given-names></name><name><surname>Seo</surname><given-names>J. H.</given-names></name><name><surname>Rah</surname><given-names>S. Y.</given-names></name><name><surname>Kim</surname><given-names>H. M.</given-names></name><name><surname>Jeong</surname><given-names>H. J.</given-names></name></person-group> (<year>2014</year>). <article-title>The therapeutic efficacy of &#x003b1;-pinene in an experimental mouse model of allergic rhinitis.</article-title>
<source><italic>Int. Immunopharmacol.</italic></source>
<volume>23</volume>
<fpage>273</fpage>&#x02013;<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2014.09.010</pub-id>
<?supplied-pmid 25242385?><pub-id pub-id-type="pmid">25242385</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nik Norulaini</surname><given-names>N. A.</given-names></name><name><surname>Anuar</surname><given-names>O.</given-names></name><name><surname>Omar</surname><given-names>A. K. M.</given-names></name><name><surname>Abbas</surname><given-names>F. M. A.</given-names></name><name><surname>Setianto</surname><given-names>W. B.</given-names></name><name><surname>Fatehah</surname><given-names>M. O.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Optimization of SC&#x02013;CO2 extraction of zerumbone from <italic>Zingiber zerumbet</italic> (L) Smith.</article-title>
<source><italic>Food Chem.</italic></source>
<volume>114</volume>
<fpage>702</fpage>&#x02013;<lpage>705</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2008.09.075</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Passos</surname><given-names>G. F.</given-names></name><name><surname>Fernandes</surname><given-names>E. S.</given-names></name><name><surname>da Cunha</surname><given-names>F. M.</given-names></name><name><surname>Ferreira</surname><given-names>J.</given-names></name><name><surname>Pianowski</surname><given-names>L. F.</given-names></name><name><surname>Campos</surname><given-names>M. M.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Anti-inflammatory and anti-allergic properties of the essential oil and active compounds from <italic>Cordia verbenacea</italic>.</article-title>
<source><italic>J. Ethnopharmacol.</italic></source>
<volume>110</volume>
<fpage>323</fpage>&#x02013;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2006.09.032</pub-id>
<?supplied-pmid 17084568?><pub-id pub-id-type="pmid">17084568</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pawankar</surname><given-names>R.</given-names></name><name><surname>Canonica</surname><given-names>G. W.</given-names></name><name><surname>Holgate</surname><given-names>S. T.</given-names></name><name><surname>Lockey</surname><given-names>R. F.</given-names></name><name><surname>Blaiss</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <source><italic>The WAO White Book on Allergy 2013 Update.</italic></source>
<publisher-loc>Lyon</publisher-loc>: <publisher-name>World Allergy Organization</publisher-name>.</mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prakash</surname><given-names>R. O.</given-names></name><name><surname>Kumar</surname><given-names>R. K.</given-names></name><name><surname>Rabinarayan</surname><given-names>A.</given-names></name><name><surname>Kumar</surname><given-names>M. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Pharmacognostical and phytochemical studies of <italic>Zingiber zerumbet</italic> (L.) SM.</article-title>
<source><italic>Rhizome Int. J. Res. Ayurveda Pharm.</italic></source>
<volume>2</volume>
<fpage>698</fpage>&#x02013;<lpage>703</lpage>.</mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rashid</surname><given-names>R. A.</given-names></name><name><surname>Pihie</surname><given-names>A. H. L.</given-names></name></person-group> (<year>2005</year>). <article-title>The antiproliferative effects of <italic>Zingiber zerumbet</italic> extracts and fractions on the growth of human breast carcinoma cell lines.</article-title>
<source><italic>Malays. J. Pharm. Sci.</italic></source>
<volume>3</volume>
<fpage>45</fpage>&#x02013;<lpage>52</lpage>.</mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reagan-Shaw</surname><given-names>S.</given-names></name><name><surname>Nihal</surname><given-names>M.</given-names></name><name><surname>Ahmad</surname><given-names>N.</given-names></name></person-group> (<year>2016</year>). <article-title>Dose translation from animal to human studies revisited.</article-title>
<source><italic>FASEB J.</italic></source>
<volume>22</volume>
<fpage>659</fpage>&#x02013;<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1096/fj.07-9574LSF</pub-id>
<?supplied-pmid 17942826?><pub-id pub-id-type="pmid">17942826</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogerio</surname><given-names>A. P.</given-names></name><name><surname>Andrade</surname><given-names>E. L.</given-names></name><name><surname>Leite</surname><given-names>D. F.</given-names></name><name><surname>Figueiredo</surname><given-names>C. P.</given-names></name><name><surname>Calixto</surname><given-names>J. B.</given-names></name></person-group> (<year>2009</year>). <article-title>Preventive and therapeutic anti-inflammatory properties of the sesquiterpene alpha-humulene in experimental airways allergic inflammation.</article-title>
<source><italic>Br. J. Pharmacol.</italic></source>
<volume>158</volume>
<fpage>1074</fpage>&#x02013;<lpage>1087</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2009.00177.x</pub-id>
<?supplied-pmid 19438512?><pub-id pub-id-type="pmid">19438512</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rout</surname><given-names>O. P.</given-names></name><name><surname>Acharya</surname><given-names>R.</given-names></name><name><surname>Mishra</surname><given-names>S. K.</given-names></name></person-group> (<year>2011</year>). <article-title>In vitro antioxidant potentials in leaves of coleus aromaticus benth and rhizomes of <italic>Zingiber zerumbet</italic> (L.) Sm.</article-title>
<source><italic>J. Appl. Pharm. Sci.</italic></source>
<volume>1</volume>
<fpage>194</fpage>&#x02013;<lpage>198</lpage>.</mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruslay</surname><given-names>S.</given-names></name><name><surname>Abas</surname><given-names>F.</given-names></name><name><surname>Shaari</surname><given-names>K.</given-names></name><name><surname>Zainal</surname><given-names>Z.</given-names></name><name><surname>Maulidiani Sirat</surname><given-names>H.</given-names></name><name><surname>Israf</surname><given-names>D. A.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Characterization of the components present in the active fractions of health gingers (<italic>Curcuma xanthorrhiza</italic> and <italic>Zingiber zerumbet</italic>) by HPLC&#x02013;DAD&#x02013;ESIIMS.</article-title>
<source><italic>Food Chem.</italic></source>
<volume>104</volume>
<fpage>1183</fpage>&#x02013;<lpage>1191</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2007.01.067</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahebkar</surname><given-names>A.</given-names></name></person-group> (<year>2011</year>). <article-title>Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease.</article-title>
<source><italic>World J. Gastroenterol.</italic></source>
<volume>17</volume>
<fpage>271</fpage>&#x02013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v17.i2.271</pub-id>
<?supplied-pmid 21246004?><pub-id pub-id-type="pmid">21246004</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasidharan</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Saravanan</surname><given-names>D.</given-names></name><name><surname>Sundram</surname><given-names>K. M.</given-names></name><name><surname>Yoga Latha</surname><given-names>L.</given-names></name></person-group> (<year>2011</year>). <article-title>Extraction, isolation and characterization of bioactive compounds from plants&#x02019; extracts.</article-title>
<source><italic>Afr. J. Tradit. Complement. Altern. Med.</italic></source>
<volume>8</volume>
<fpage>1</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharifi-Rad</surname><given-names>M.</given-names></name><name><surname>Varoni</surname><given-names>E. M.</given-names></name><name><surname>Salehi</surname><given-names>B.</given-names></name><name><surname>Sharifi-Rad</surname><given-names>J.</given-names></name><name><surname>Matthews</surname><given-names>K. R.</given-names></name><name><surname>Ayatollahi</surname><given-names>S. A.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Plants of the Genus Zingiber as a source of bioactive phytochemicals: from tradition to pharmacy.</article-title>
<source><italic>Molecules</italic></source>
<volume>22</volume>:<issue>E2145</issue>. <pub-id pub-id-type="doi">10.3390/molecules22122145</pub-id>
<?supplied-pmid 29207520?><pub-id pub-id-type="pmid">29207520</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shieh</surname><given-names>Y. H.</given-names></name><name><surname>Huang</surname><given-names>H. M.</given-names></name><name><surname>Wang</surname><given-names>C. C.</given-names></name><name><surname>Lee</surname><given-names>C. C.</given-names></name><name><surname>Fan</surname><given-names>C. K.</given-names></name><name><surname>Lee</surname><given-names>Y. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Zerumbone enhances the Th1 response and ameliorates ovalbumin-induced Th2 responses and airway inflammation in mice.</article-title>
<source><italic>Int. Immunopharmacol.</italic></source>
<volume>24</volume>
<fpage>383</fpage>&#x02013;<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2014.12.027</pub-id>
<?supplied-pmid 25573403?><pub-id pub-id-type="pmid">25573403</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>N. R.</given-names></name><name><surname>Shin</surname><given-names>I. S.</given-names></name><name><surname>Jeon</surname><given-names>C. M.</given-names></name><name><surname>Hong</surname><given-names>J. M.</given-names></name><name><surname>Kwon</surname><given-names>O. K.</given-names></name><name><surname>Kim</surname><given-names>H. S.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title><italic>Zingiber mioga</italic> (Thunb.) Roscoe attenuates allergic asthma induced by ovalbumin challenge.</article-title>
<source><italic>Mol. Med. Rep.</italic></source>
<volume>12</volume>
<fpage>4538</fpage>&#x02013;<lpage>4545</lpage>. <pub-id pub-id-type="doi">10.3892/mmr.2015.3914</pub-id>
<?supplied-pmid 26063513?><pub-id pub-id-type="pmid">26063513</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>C. B.</given-names></name><name><surname>Nongalleima</surname><given-names>K. H.</given-names></name><name><surname>Brojendrosingh</surname><given-names>S.</given-names></name><name><surname>Ningombam</surname><given-names>S.</given-names></name><name><surname>Lokendrajit</surname><given-names>N.</given-names></name><name><surname>Singh</surname><given-names>L. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Biological and chemical properties of <italic>Zingiber zerumbet</italic> Smith: a review.</article-title>
<source><italic>Phytochem. Rev.</italic></source>
<volume>11</volume>
<fpage>113</fpage>&#x02013;<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1007/s11101-011-9222-4</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>K.</given-names></name><name><surname>Chaturvedi</surname><given-names>R.</given-names></name><name><surname>Barry</surname><given-names>D. P.</given-names></name><name><surname>Coburn</surname><given-names>L. A.</given-names></name><name><surname>Asim</surname><given-names>M.</given-names></name><name><surname>Lewis</surname><given-names>N. D.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>The apolipoprotein E-mimetic peptide COG112 inhibits NF-kappaB signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis.</article-title>
<source><italic>J. Biol. Chem.</italic></source>
<volume>286</volume>
<fpage>3839</fpage>&#x02013;<lpage>3850</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.176719</pub-id>
<?supplied-pmid 21115487?><pub-id pub-id-type="pmid">21115487</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sirirugsa</surname><given-names>P.</given-names></name></person-group> (<year>1995</year>). <article-title>The genus Hedychium (Zingiberaceae) in Thailand.</article-title>
<source><italic>Nord. J. Bot.</italic></source>
<volume>15</volume>
<fpage>301</fpage>&#x02013;<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1111/j.1756-1051.1995.tb00156.x</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somchit</surname><given-names>M. N.</given-names></name><name><surname>Shukriyah</surname><given-names>M. H. N.</given-names></name><name><surname>Bustamam</surname><given-names>A. A.</given-names></name><name><surname>Zuraini</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Anti-pyretic and analgesic activity of <italic>Zingiber zerumbet</italic>.</article-title>
<source><italic>Int. J. Pharm.</italic></source>
<volume>1</volume>
<fpage>277</fpage>&#x02013;<lpage>280</lpage>. <pub-id pub-id-type="doi">10.3923/ijp.2005.277.280</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sulaiman</surname><given-names>M. R.</given-names></name><name><surname>Mohamad</surname><given-names>T. A. S. T.</given-names></name><name><surname>Mossadeq</surname><given-names>W. M. S.</given-names></name><name><surname>Moin</surname><given-names>S.</given-names></name><name><surname>Yusof</surname><given-names>M.</given-names></name><name><surname>Mokhtar</surname><given-names>A. F.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Antinociceptive activity of the essential oil of <italic>Zingiber zerumbet</italic>.</article-title>
<source><italic>Planta Med.</italic></source>
<volume>76</volume>
<fpage>107</fpage>&#x02013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1055/s-0029-1185950</pub-id>
<?supplied-pmid 19637111?><pub-id pub-id-type="pmid">19637111</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>D-Limonene: safety and clinical applications.</article-title>
<source><italic>Altern. Med. Rev.</italic></source>
<volume>12</volume>
<fpage>259</fpage>&#x02013;<lpage>264</lpage>. <?supplied-pmid 18072821?><pub-id pub-id-type="pmid">18072821</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takada</surname><given-names>Y.</given-names></name><name><surname>Murakami</surname><given-names>A.</given-names></name><name><surname>Aggarwal</surname><given-names>B. B.</given-names></name></person-group> (<year>2005</year>). <article-title>Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastaticgene expression, upregulation of apoptosis, and downregulation of invasion.</article-title>
<source><italic>Oncogene</italic></source>
<volume>24</volume>
<fpage>6957</fpage>&#x02013;<lpage>6969</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1208845</pub-id>
<?supplied-pmid 16007145?><pub-id pub-id-type="pmid">16007145</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tewtrakul</surname><given-names>S.</given-names></name><name><surname>Subhadhirasakul</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Anti-allergic activity of some selected plants in the Zingiberaceae family.</article-title>
<source><italic>J. Ethnopharmacol.</italic></source>
<volume>109</volume>
<fpage>535</fpage>&#x02013;<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2006.08.010</pub-id>
<?supplied-pmid 16978816?><pub-id pub-id-type="pmid">16978816</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>K.</given-names></name><name><surname>Yano</surname><given-names>S.</given-names></name><name><surname>Horie</surname><given-names>T.</given-names></name><name><surname>Kachia</surname><given-names>R. S.</given-names></name><name><surname>Ikegami</surname><given-names>F.</given-names></name><name><surname>Yamamoto</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>1994</year>). <comment>Borneol as allergy inhibitor. Japan Patent No. JP06211713</comment>
<publisher-loc>Chiyoda</publisher-loc>: <publisher-name>Japan Patent Office</publisher-name>.</mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yob</surname><given-names>N. J.</given-names></name><name><surname>Jofrry</surname><given-names>S. M.</given-names></name><name><surname>Affandi</surname><given-names>M. M.</given-names></name><name><surname>The</surname><given-names>L. K.</given-names></name><name><surname>Salleh</surname><given-names>M. Z.</given-names></name><name><surname>Zakaria</surname><given-names>Z. A.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>Zingiber zerumbet</italic> (L.) Smith: a review of its ethnomedicinal, chemical, and pharmacological uses.</article-title>
<source><italic>Evid. Based Complement. Alternat. Med.</italic></source>
<volume>2011</volume>:<issue>543216</issue>. <pub-id pub-id-type="doi">10.1155/2011/543216</pub-id>
<?supplied-pmid 27462359?><pub-id pub-id-type="pmid">27462359</pub-id></mixed-citation></ref></ref-list></back></article>